within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05C_IrrigatingSolutions.B05CX04_Mannitol;

model Mannitol
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 1.1666666666666666e-06,
    adminDuration = 600,
    adminMass = 100 / 1000000,
    adminCount = 1,
    Vd = 0.00025,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Mannitol</td></tr><tr><td>ATC code:</td><td>B05CX04</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>100</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.25</td><td>L</td></tr>
    <tr><td>clearance:</td><td>70</td><td>ml/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Mannitol is an osmotic diuretic commonly used to reduce intracranial pressure and treat cerebral edema. It is also used to promote diuresis in renal failure and for excretion of toxic substances. Mannitol is approved for intravenous use in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adults following intravenous administration.</p><h4>References</h4><ol><li><p>Deferm, N, et al., &amp; Allegaert, K (2021). Glomerular Filtration Rate in Asphyxiated Neonates Under Therapeutic Whole-Body Hypothermia, Quantified by Mannitol Clearance. <i>Clinical pharmacokinetics</i> 60(7) 897–906. DOI:<a href=\"https://doi.org/10.1007/s40262-021-00991-6\">10.1007/s40262-021-00991-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33611729/\">https://pubmed.ncbi.nlm.nih.gov/33611729</a></p></li><li><p>Hahn, RG (2023). Isotonic saline causes greater volume overload than electrolyte-free irrigating fluids. <i>Journal of basic and clinical physiology and pharmacology</i> 34(6) 717–723. DOI:<a href=\"https://doi.org/10.1515/jbcpp-2021-0032\">10.1515/jbcpp-2021-0032</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34563101/\">https://pubmed.ncbi.nlm.nih.gov/34563101</a></p></li><li><p>Kaneda, K, et al., &amp; Todd, MM (2010). Pharmacokinetic characteristics of bolus-administered mannitol in patients undergoing elective craniotomy. <i>Journal of clinical pharmacology</i> 50(5) 536–543. DOI:<a href=\"https://doi.org/10.1177/0091270009348973\">10.1177/0091270009348973</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20051588/\">https://pubmed.ncbi.nlm.nih.gov/20051588</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.B.B05CX04 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Mannitol;
